Monday, November 16, 2026
HomeCorporateHDFC Mutual Fund launches fifth Cancer Cure Fund, raises ₹292 crore to...

HDFC Mutual Fund launches fifth Cancer Cure Fund, raises ₹292 crore to date

Mumbai, November 16, 2026: HDFC Asset Management Company Limited (HDFC AMC), investment manager to HDFC Mutual Fund, has launched the fifth edition of its Cancer Cure Fund, in partnership with the Indian Cancer Society (ICS), to support treatment for underprivileged cancer patients. The new scheme, HDFC Charity Fund for Cancer Cure (Feb 2030), is a fixed maturity plan with a tenure of 1,169 days, and its new fund offer (NFO) is open from November 16 to November 30, 2026.

Since its inception in 2011 as India’s first cancer fund, the Cancer Cure series has raised ₹292.41 crore for ICS, including direct contributions from HDFC AMC, and has supported the treatment of 17,435 patients across 22 hospitals as of August 31, 2026. Nearly one in four beneficiaries has been a child aged 15 or below.

Donation options and fund structure

Under the latest scheme, investors can opt to donate either 50% or 75% of their income distribution cum capital withdrawal (IDCW) to ICS, with HDFC AMC matching the donation, subject to a cap of ₹16 crore per financial year. The investment amount will be returned to investors upon maturity. HDFC AMC has also waived the investment management and advisory fee for this scheme.

The fund is benchmarked against the NIFTY Medium Duration Debt Index A-III and has a potential risk class of A-III. Fund managers for the scheme are Anil Bamboli and Gopal Agrawal (for overseas investments). The minimum application amount is ₹50,000, with subsequent investments in multiples of ₹1,000. Both direct and regular plans are available, each offering a 50% or 75% IDCW donation option.

Impact and industry context

According to ICMR-NCDIR, India recorded an estimated 14,61,427 new cancer cases in 2022, with a new diagnosis every 22 seconds. The financial burden of treatment remains a significant barrier for many families, making such initiatives crucial for timely access to care.

Statements from HDFC AMC and ICS

Navneet Munot, Managing Director and Chief Executive Officer of HDFC AMC, said the Cancer Cure initiative has brought together investors, the industry, and ICS to address a cause that affects countless families, with ₹292 crore contributed and thousands of patients supported to date.

Usha Thorat of the Indian Cancer Society noted that the support from HDFC Mutual Fund’s Cancer Cure series has enabled financial assistance to over 17,000 patients across 22 hospitals, providing hope to families during difficult times.

HDFC AMC, incorporated in 1999 and approved by SEBI in 2000, manages a diversified asset mix across equity and fixed income, with a nationwide distribution network.


Disclaimer: This article is based on a press release provided by the concerned organisation and has been edited for style and clarity with the assistance of AI tools. BusinessFortnight does not verify, endorse, or take responsibility for the claims, figures, or statements made in the original release.

Ravindra Soni
Ravindra Sonihttps://businessfortnight.com
Senior journalist with 38 years of experience in print and digital media. Former Executive Editor. Founder and Editor of BusinessFortnight, covering business, economy, and policy news from Madhya Pradesh and across India.
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments